Antidepressant Duloxetine Recalled Nationwide Over Carcinogenic Impurity

Nearly 375,000 bottles of the antidepressant duloxetine have been recalled across the nation. The recall stems from elevated levels of N-nitroso-duloxetine, a potentially cancer-causing impurity, found during testing. This Class II recall indicates a risk of temporary or reversible adverse health consequences.